None listed
Conditions
Interventions
Experimental group:Use Calendula Moisturizing Repair Spray and Mask After Laser Surgery
Control group:Using a Mask After Laser Surgery
Sponsors
Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years, gender is not limited; 2. Good health, no history of serious diseases such as cardiovascular system, digestive system, endocrine system, immune system, nervous system; no history of mental and psychological abnormalities; 3. In line with 1064nm fractional picosecond laser facial treatment indications, such as acne scars, photoaging, enlarged pores, etc.; 4. No skin barrier damage, no obvious telangiectasia, chloasma, etc.; 5. The subjects fully understand the content of the experiment, voluntarily participate in the experiment, and have signed the informed consent; 6. There is no history of skin chemical peeling, other history of photoelectric therapy or participation in other clinical research that affects the observation of this test within 3 months; 7. No history of drug allergy, skin tumor, dermatitis, eczema and other skin diseases; 8. Be able to conduct treatment, data collection, and cooperate with visits according to research requirements.
Exclusion criteria
Exclusion criteria: 1. Those who are known to be allergic to the active ingredients or excipients of the research cosmetics; 2. Those with obvious signs of bacterial, fungal, viral or other pathogen infection on the facial skin, such as: acne, folliculitis, herpes simplex, flat wart, etc.; 3. Those who have a history of herpes simplex in the past; 4. Those who are preparing for pregnancy, pregnancy and lactation; 5. Those who use Chinese herbal medicine, sedatives or other addictive drugs; 6. Alcoholics, mentally ill patients, or unable to cooperate with treatment and research as prescribed by a doctor; 7. Patients with a history of photosensitivity diseases (chronic actinic dermatitis, systemic lupus erythematosus, etc.), skin photosensitivity, porphyrin allergy, porphyria, etc.; 8. Oral or external use of photosensitizing drugs or hormones.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transepidermal water loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reaction rate;Patient satisfaction; | — |
Countries
China
Contacts
Public ContactDong Jiying
Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed